Correction: Initial neutrophil-to-lymphocyte ratio alongside SLEDAI as predictors

Overview

This correction addresses inaccuracies in figure captions related to a cohort study on predictors of low disease activity in lupus. The corrected captions clarify the calibration curves and decision curve analysis for the models used in the study.

Background

Systemic lupus erythematosus (SLE) is a complex autoimmune disorder where achieving low disease activity is crucial for patient outcomes. The use of inflammatory indices, such as the neutrophil-to-lymphocyte ratio (NLR) and the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), provides a cost-effective means to assess disease activity.

Data Highlights

No new numerical data presented in this correction.

Key Findings

• The correction clarifies that the captions for Figures 2 and 3 were incorrectly identical in the original publication.
• Figure 2 now accurately describes calibration curves for three LLDAS prediction models.
• Figure 3 provides a corrected description of the decision curve analysis for the LLDAS prediction models.
• The study originally reported that baseline NLR combined with SLEDAI predicts LLDAS at one year.
• Corrected figures are essential for accurate interpretation of the study's findings.

Clinical Implications

Clinicians should refer to the corrected figures for a better understanding of the predictive models for low disease activity in SLE.

Conclusion

This correction ensures clarity in the presentation of data related to predictors of low disease activity in lupus.

Related Resources & Content

1. Zou Y, Yu R, Yang K, et al., Frontiers in Immunology, 2026 -- Correction: Initial neutrophil-to-lymphocyte ratio alongside SLEDAI as predictors of low disease activity in lupus after one year: a cohort analysis
2. Clinical Rheumatology — Factors Influencing and Protective Elements of Achieving Low Disease Activity in Systemic Lupus Erythematosus: Insights from a Prospective Study in a Chinese Population
3. Clinical Rheumatology — Factors Influencing Disease Activity Improvement in Initially Hospitalized Systemic Lupus Erythematosus Patients: A Retrospective Multicenter Study of a Chinese Population
4. Clinical Rheumatology — Initial Disease Activity as a Prognostic Indicator for Outcomes in Systemic Lupus Erythematosus Patients: Insights from a Retrospective Analysis of the COMOSLE-EGYPT Study
5. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus - PubMed
6. Baseline neutrophil-to-lymphocyte ratio combined with SLEDAI predicts lupus low disease activity state at 1 year: a cohort study - PubMed
7. Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study